Advertisement

Ads Placeholder
Loading...

Haleos Labs Ltd.

SMSLIFE.BOBSE
Healthcare
Biotechnology
1299.00
45.20(3.61%)
Indian Market opens in 34h 46m

Haleos Labs Ltd. Fundamental Analysis

Haleos Labs Ltd. (SMSLIFE.BO) shows weak financial fundamentals with a PE ratio of 20.82, profit margin of 5.67%, and ROE of 9.50%. The company generates $3.3B in annual revenue with weak year-over-year growth of -3.04%.

Key Strengths

No significant strengths identified.

Areas of Concern

ROE9.50%
Operating Margin9.19%
Cash Position0.40%
PEG Ratio2.51
We analyze SMSLIFE.BO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 47.6/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
47.6/100

We analyze SMSLIFE.BO's fundamental strength across five key dimensions:

Efficiency Score

Weak

SMSLIFE.BO struggles to generate sufficient returns from assets.

ROA > 10%
4.75%

Valuation Score

Moderate

SMSLIFE.BO shows balanced valuation metrics.

PE < 25
20.82
PEG Ratio < 2
2.51

Growth Score

Weak

SMSLIFE.BO faces weak or negative growth trends.

Revenue Growth > 5%
-3.04%
EPS Growth > 10%
-20.68%

Financial Health Score

Excellent

SMSLIFE.BO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.34
Current Ratio > 1
1.06

Profitability Score

Weak

SMSLIFE.BO struggles to sustain strong margins.

ROE > 15%
9.50%
Net Margin ≥ 15%
5.67%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is SMSLIFE.BO Expensive or Cheap?

P/E Ratio

SMSLIFE.BO trades at 20.82 times earnings. This indicates a fair valuation.

20.82

PEG Ratio

When adjusting for growth, SMSLIFE.BO's PEG of 2.51 indicates potential overvaluation.

2.51

Price to Book

The market values Haleos Labs Ltd. at 1.89 times its book value. This may indicate undervaluation.

1.89

EV/EBITDA

Enterprise value stands at 6.53 times EBITDA. This is generally considered low.

6.53

How Well Does SMSLIFE.BO Make Money?

Net Profit Margin

For every $100 in sales, Haleos Labs Ltd. keeps $5.67 as profit after all expenses.

5.67%

Operating Margin

Core operations generate 9.19 in profit for every $100 in revenue, before interest and taxes.

9.19%

ROE

Management delivers $9.50 in profit for every $100 of shareholder equity.

9.50%

ROA

Haleos Labs Ltd. generates $4.75 in profit for every $100 in assets, demonstrating efficient asset deployment.

4.75%

Following the Money - Real Cash Generation

Operating Cash Flow

Haleos Labs Ltd. produces operating cash flow of $457.73M, showing steady but balanced cash generation.

$457.73M

Free Cash Flow

Haleos Labs Ltd. produces free cash flow of $262.40M, offering steady but limited capital for shareholder returns and expansion.

$262.40M

FCF Per Share

Each share generates $86.79 in free cash annually.

$86.79

FCF Yield

SMSLIFE.BO converts 6.74% of its market value into free cash.

6.74%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

20.82

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.51

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.89

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.18

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.34

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.06

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.09

vs 25 benchmark

ROA

Return on assets percentage

0.05

vs 25 benchmark

ROCE

Return on capital employed

0.12

vs 25 benchmark

How SMSLIFE.BO Stacks Against Its Sector Peers

MetricSMSLIFE.BO ValueSector AveragePerformance
P/E Ratio20.8228.45 Better (Cheaper)
ROE9.50%763.00% Weak
Net Margin5.67%-45265.00% (disorted) Weak
Debt/Equity0.340.34 Neutral
Current Ratio1.062795.60 Neutral
ROA4.75%-16588.00% (disorted) Weak

SMSLIFE.BO outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Haleos Labs Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-18.02%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-49.05%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-18.96%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ